Elsevier expands article submission screening tool to strengthen research credibility

Elsevier has expanded its Check Integrity screening tool across nearly 2,000 of its journals to help identify potential ethical issues in research papers before publication, following a successful pilot phase.

The tool is designed to detect potential breaches of publishing ethics policies, such as unauthorized authorship changes and editorial conflicts of interest so that these can be addressed by a team of experts.

So far, a significant number of potential issues raised have led to corrective action to ensure compliance with our ethics policies, demonstrating the tool’s value in preventing future corrections to the record.

Check Integrity reviews submissions automatically and flags concerns for specialist integrity analysts, who assess the findings and take action if needed. This allows editors to focus on evaluating credible research while improving efficiency and trust in the publishing process.

Laura Hassink, MD of STM Journals, said: “Check Integrity represents a meaningful leap in safeguarding the integrity of the research we publish. By handling the screening and initial communications, Check Integrity frees editors to focus on evaluating high-quality, authentic research, making the publication process faster and more reliable for authors and readers alike.”

The tool is designed to adapt as new risks emerge and helps address growing pressures on researchers and editors as submission volumes increase.

Prof. Sarah Spencer, Co-Editor-in-Chief of Neuroscience journal at RMIT University, added: “The Check Integrity tool is a fantastic weapon in our arsenal against those who would try to cheat the system.”

Check Integrity is part of Elsevier’s broader investment in technology and expert oversight to protect research integrity and maintain confidence in academic publishing.

エルゼビアについて

エルゼビアは、先端情報と意思決定を支援しています。1世紀以上にわたり、人類の進歩のため先端科学とヘルスケアの進歩に貢献してきました。私たちは、170か国にわたるアカデミアや企業の研究コミュニティ、医師、看護師、未来の医療従事者、教育者の皆さまの重要な活動をサポートしています。これは、信頼できるエビデンスに基づく科学・医療コンテンツと高度なAI技術を組み合わせた革新的なソリューションにより知見の集積や重要な意思決定を支援することで実現しています。また、私たちは、これらの価値を製品や企業文化に組み込み、コミュニティとの協働を通じて、インクルージョンと持続可能性を推進しています。エルゼビア財団は、世界中の研究と医療のパートナーシップを支援しています。

エルゼビアは、専門家およびビジネス向けの情報分析および意思決定ツールのグローバルプロバイダーであるRELX Groupの一事業を担っています。詳細につきましては、www.elsevier.comまたはソーシャルメディア@Elsevier Connectをご覧ください。